Mammen, E.F. : Natural Proteinase Inhibitors in Extracorporeal Circulation. Ann N.Y. Acad Sci.146: 754, 1968 .
2.
Beall, A.C., Yow, E.M., Bloodwell, R.D., Hallman, G.L., and Cooley, D.A.: Open Heart Surgery without Blood Transfusion. Arch. Surg.94: 567, 1967.
3.
Tice, D.A. and Worth, M.H.: Recognition and Treatment of Postoperative Bleeding Associated with Open-Heart Surgery. Ann. N.Y. Acad. Sci.146: 745, 1968 .
4.
Kevy, S.V., Glickman, R.M., Bernhard, W.F., Diamond, L.K., and Gross, R.E.: The Pathogenesis and Control of the Hemorrhagic Defect in Open Heart Surgery . Surg. Gyn. & Obstet.123: 313, 1966 .
5.
Wright, T.A. , Darte, J., and Mustard, W.T.: Postoperative Bleeding After Extracorporeal Circulation. Canadian J. Surg.2: 142, 1959.
6.
Trimble, A.S. , Herst, R., Grady , M., and Crookston, J.H.: Blood Loss in Open Heart Surgery. Arch. Surg.93: 323, 1966.
7.
Blomback, M. , Noren, I., and Senning, A.: Coagulation Disturbances during Extracorporeal Circulation and the Postoperative Period . Acta Chir. Scand.127: 433, 1964.
8.
Tsuji, H.K., Redington, J.V., and Kay, J.H.: The Study of Fibrinolytic and Coagulation Factors During Open Heart Surgery . Ann. N.Y. Acad. Sci.146: 763, 1968 .
9.
Woods, J.E., Kirklin, J.W., Owen, C.A., Thompson, J.H., and Taswell, H.F.: Effect of Bypass Surgery on Coagulation Sensitive Clotting Factors . Mayo Clin. Proc.42: 724, 1967.
10.
Derman, U.M. , Rand, P.W., and Barker, N.: Fibrinolysis after Cardiopulmonary Bypass and its Relationship to Fibrinogen. J. Thorac. Cardiovasc. Surg.51: 223, 1966.
11.
Wuelfing, D. , and Brandau, K.P.: Fibrinolytic Activity After Surgery. Minn. Med.51: 1503, 1968.
12.
Ygge, J.: Changes in Blood Coagulation and Fibrinolysis During the Postoperative Period . Am. J. Surg.119: 225, 1970.
13.
Tsitouris, G., Bellet, S., Eilberg , R., Feinberg, L., and Sandberg, H.: Effects of Major Surgery on Plasmin-Plasminogen Systems. Arch. Int. Med.108: 98, 1961.
14.
Menon, I.S. : A Study of the Possible Correlation of Euglobulin Lysis Time and Dilute Blood Clot Lysis Time in the Determination of Fibrinolytic Activity. Lab. Pract.334, 1968.
15.
Graeff, H. and Beller, F.K.: Fibrinolytic Activity in Whole Blood, Dilute Blood, and Euglobulin Lysis Time Tests. In Thrombosis and Bleeding Disorders. Bang, N.U. ed. Verlag, N.Y.1971.
16.
Signori, E.E. , Penner, J.A., and Kahn, D.R.: Coagulation Defects and Bleeding in Open Heart Surgery. Ann Thorac. Surg.8: 521, 1969.
17.
Brooks, D.H. and Bahnson, H.T.: An Outbreak of Hemorrhage Following Cardiopulmonary Bypass. J. Thorac. Cardiovasc. Surg.63: 449, 1972.
18.
O'Neill, J.A. , Ende, N., Collins , I.S., and Collins, H.A.: A Quantitative Determination of Perfusion Fibrinolysis. J. Thorac. Cardiovasc. Surg.51: 777, 1966.
19.
von Kaulla, K.N. and Swan, H.: Clotting Deviations in Man During Cardiac Bypass: Fibrinolysis and Circulating Anticoagulant. J. Thoracic Surg.36: 519, 1958.
20.
Gans, H., Subramanian, V., John, S., Castaneda, A.R., and Lillehei, C.W.: Theoretical and Practical (Clinical) Considerations Concerning Proteolytic Enzymes and Their Inhibitors with Particular Reference to Changes in the Plasminogen-Plasmin System Observed During Assisted Circulation in Man. Ann. N.Y. Acad. Sci.146: 721, 1968.
21.
Verska, J.J. : To Editor. Ann. Thor. Surg.13: 87, 1972.
22.
Verska, J.J. , Lonser, E.R., and Brewer, L.A.: Predisposing Factors and Management of Hemorrhage Following Open Heart Surgery. J. Cardiovasc. Surg.13: 361, 1972.
23.
Palester-Chlebowozyk, M., Strzyzewska , E., Sitkowski, W., and Olender, K.: Detection of the Intravascular Coagulation of Blood: Results of the Paracoagulation Test in Patients Undergoing Open Heart Surgery with Extravascular Coagulation. PolishMed. J.11: 59, 1972.
24.
Porter, J.M. and Silver, D.: Alterations in Fibrinolysis and Coagulation Associated with Cardiopulmonary Bypass. J. Thor. Cardiovasc. Surg.56: 869, 1968.
25.
Gomes, M.R. and McGoon, D.C.: Bleeding Patterns After Open Heart Surgery . J. Thorac. Cardiovasc. Surg.60: 87, 1970.
26.
deVries, S.I. , van Creveld, S., Groen , P., Muller, E., and Wettermark , M.: Studies on the Coagulation of the Blood in Patients Treated with Extracorporeal Circulation . Thromb. et. Diath. Haemorrh.5: 426, 1961.
27.
Penick, G.D. , Averette, H.E., Peters , R.M., and Brinkhous , K.M.: The Hemorrhagic Syndrome Complicating Extracorporeal Shunting of Blood: An Experimental Study of its Pathogenesis. Thromb. et. Diath. Haemorrh.2: 218-225, 1958.
28.
Casteneda, A.R.: Must Heparin be Neutralized Following Open Heart Operations. J. Thor. Cardiovasc. Surg.52: 716, 1966.
29.
Holswade, G.R. , Nachman, R.L., and Killip, T.: Thrombocytopathies in Patients with Open Heart Surgery. Arch. Surg.94: 365, 1967.
Bowie, E.J.W. , Owen, C.A., and Thompson , J.H.: Platelet Adhesiveness in von Willebrands Disease. Am. J. Clin. Path.52: 69, 1969.
32.
Bowie, E.J.W. and Owen, C.A.: The Value of Measuring Platelet Adhesiveness in the Diagnosis of Bleeding Diseases. Am. J. Clin. Path.60: 302, 1973.
33.
Quick, A.J., Stanldy-Brown, M. and Bancroft, F.W.: A Study of the Coagulation Defect in Hemophilia and in Jaundice. Amer. J. Med. Sci.190: 501, 1935.
34.
Proctor, R.R. and Rapaport, S.I.: The Partial Thromboplastin Time with Kaolin . Amer. J. Clin. Path.36: 212, 1961.
35.
Hougie, C.: Fundamentals of Blood Coagulation in Clinical Medicine. McGraw-Hill Book Co. Inc., New York, 1963.
36.
Morse, E.E., Panek, S., and Menga, R.: Automated Fibrinogen Determination. Amer. J. Clin. Path.55: 671, 1971.
37.
Kidder, W.R. , Logan, L.J., Rapaport , S.I., and Patch, M.J.: The Plasmin Protamine Paracoagulation Test: Clinical and Laboratory Evaluation. Amer. J. Clin. Path.58: 675, 1972.
38.
Lewis, J.H. , Wilson, J.H., and Brandon, J.M.: Counterelectrophoresis 3 Test for Molecules Immunologically Similar to Fibrinogen. Amer. J. Clin. Path.58: 400, 1972.
39.
Soloway, H.B. , Cornett, B.M., Donahoo , J.V., and Cox, S.P.: Differentiation of Bleeding Diatheses Which Occur Following Protamine Correction of Heparin Anticoagulation. Amer. J. Clin. Path.60: 188, 1973.
40.
Bick, R.L., Bishop, R.C., and Shanbrom, E.: Fibrinolytic Activity in Acute Myocardial Infarction. Amer. J. Clin. Path.57: 359, 1972.
41.
Wintrobe, M.M. : in Clinical Hematology6th Ed. Lea and Febiger, Philadelphia , 1967.
42.
Brecker, G. and Cronkite, E.D.: Morphology and Enumeration of Human Blood Platelets. J. Applied Physiol. 3: 365, 1950.
43.
Schatz, I.J. and Hathaway, J.C.: Heparin and ThrombinTimes. J.A.M.A.186: 740, 1963.
44.
Ollendorff, P.: The Nature of the Anticoagulant Effect of Heparin, Protamine, Polybrene, and Toluidine Blue. Scand. J. Clin. Lab. Invest.14: 267, 1962.
45.
Pechet, L.: Fibrinolysis. N. Eng. J. Med.273: 966, 1965 .
46.
Sherry, S., Fletcher, A.P., and Alkjersig, N.: Fibrinolysis and Fibrinolytic Activity in Man. Physiological Rev.39: 343, 1959.
47.
Sharp, A.A. : The Significance of Fibrinolysis. Proc. Roy. Soc. Biol.173: 311, 1969.
48.
Kowalski, E. : Fibrinogen Derivatives and Their Biologic Activities . Semin. Hematol.5: 45, 1968.
49.
Larrieu, M.J. : Action of Fibrinogen Degradation Products and Fibrin Monomer Soluble Complexes on Platelet Aggregation. Scand. J. Haematol. Suppl. 13: 273, 1971.
50.
Kowalski, E. , Kopec, M., and Wegrzynowicz , Z.: Influence of Fibrinogen Degradation Products on Platelet Aggregation, Adhesiveness, and Viscous Metamorphosis . Thromb. et Diath. Haemorrh.10: 406, 1964.
51.
Hellum, A.J. : The Adhesiveness of Blood Platelets in vitro . Scand. J. Clin. Lab. Invest.51: 1, 1960.
52.
Unpublished observations.
53.
Adams, T., Schultz, L., and Goldberg, L.S.: Platelet Function Abnormalities in the Myeloproliferative Disorders . In press, Scand. J. Haematology.
54.
Mustard, J.F. and Packhan, M.A.: Factors Influencing Platelet Function: Adhesion, Release, and Aggregation. Pharmacol. Rev.23: 97, 1970.
55.
Kowalski, E. : Fibrinogen Derivatives and Their Biologic Activities . Seminars Hematol.5: 45, 1968.
56.
Kowalski, E. , Kopec, M., and Wegrzynowicz , Z.: Influence of Fibrinogen Degradation Products on Platelet Aggregation, Adhesiveness, and Viscous Metamorphosis . Thromb. Diath. Haemorrh.10: 406, 1964.
57.
Solum, N.O. , Rigollot, C., Budzynski , A.Z., and Marder, V.J.: A Quantitative Evaluation of the Inhibition of Platelet Aggregation by Low Molecular Weight Degradation Products of Fibrinogen . Brit. J. Haematol.24: 419, 1973.
58.
Bowie, E.J.W. and Owen, C.A.: Some Factors Influencing Platelet Retention in Glass Bead Columns Including the Influence of Plastics. Am. J. Clin. Path.56: 479, 1971.